Novartis enrolled 340 subjects with biopsy-proven IgAN and proteinuria levels of a minimum of 1 g/day in the trial. Credit: Michael Derrer Fuchs / Shutterstock.com. Novartis has unveiled interim ...

Pegcetacoplan was found to be well-tolerated in the trial in adults with post-transplant recurrence of C3G or IC-MPGN. Credit: sweet_tomato / Shutterstock.com. Apellis Pharmaceuticals and Sobi have ...

Avutometinib won orphan drug designation from the US Food and Drug Administration (FDA) in March 2024. The agency designated ...

Eight patients undergoing haemodialysis were enrolled into the first in human trial which demonstrated safety and efficacy of ...

Heartbeam AI plus vectorcardiography (VCG) outperformed an expert panel of three cardiologists by 40% in detecting atrial ...

Terran Biosciences is waiting for KarXT to receive approval from the FDA before initiation two Phase I trials of its prodrug TerXT. Image credit: New Africa / Shutterstock. Terran Biosciences is ...

Johnson & Johnson’s and subsidiary Janssen have both applied for regulatory approval for Tremfya to the EMA and FDA. Image credit: Shutterstock / Skorzewiak. Johnson and Johnson’s Tremfya (guselkumab) ...

The safety profile of Eli Lilly’s mirikizumab was in line with its already reported data in ulcerative colitis patients. Credit: Jennie Book / Shutterstock. Eli Lilly has reported promising results ...

In the trial in asthma patients, rilzabrutinib was found to be well tolerated throughout the 12-week treatment period. Credit: voronaman / Shutterstock. Sanofi has announced positive outcomes from a ...

The trial is designed to assess the efficacy and safety of ZL-1102 as a topical treatment for psoriasis. Credit: Ternavskaia Olga Alibec / Shutterstock. Zai Lab has dosed the first subject in a Phase ...

The study is assessing the safety, tolerability, and biological activity of LD IL-2 in mild-to-moderate Alzheimer’s patients. Credit: fizkes / Shutterstock. Coya Therapeutics has announced the ...